Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Crossover Trial to Assess the Tolerability of GnRH Analogue Administration in Patients With Advanced Prostate Cancer

NCT01161563 is registered in ClinicalTrials.gov with Watson Pharmaceuticals as lead sponsor.

NCT NCT01161563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01161563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Crossover Trial to Assess the Tolerability of GnRH Analogue Administration in Patients With Advanced Prostate Cancer
Lead sponsor
Watson Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2010
Completion date
April 30, 2011
Enrollment
118 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer